Disruption of the GCN5-CITED2-PKA signalling module (such as that achieved by CITED2 depletion) also suppressed gluconeogenesis and ameliorated diabetes, suggesting that this module is a promising pharmacological target for treatment of obesity and type 2 diabetes. The gene discussed is CITED2; the disease is Obesity.